Technical optimization to improve the application of plastics in medical industry
Technical optimization to improve the application of plastics in medical industry
Health care consumption will double growth. Southeast Asia is expected to grow strongly as the population ages and the population grows. Will promote investment in medical equipment production. Policies and regulations in the health care industry are also increasingly regulated, and as costs and concerns over health care increase, the quality of medical devices becomes particularly important. Asian countries are increasing their investment in the health care market as they grow. Per capita healthcare consumption in the asia-pacific region is much lower than in North America and Europe, but per capita medical consumption is rising as the country attaches more importance to national health and happiness.
Medical device makers are gradually replacing traditional production materials like metal and glass with plastic. At present, plastic production is more flexible. The market has a greater dependence on daily polymer, and with the development of technology optimization and application of different kinds of polymers, this will accelerate the application of plastics in medical devices. Technology continuously optimize and improve the application of plastics in medical industry
The health care industry is less affected by the economy than other industries. This keeps the demand for medical plastics rising. The market is in a period of growth and is expected to continue to grow because of the growing overseas investment in medical technology. In 2013, the sales volume of medical plastic in Asia and the Pacific reached 62,000 tons, and the annual compound growth rate is expected to increase to 76,000 tons in 2017 from the year 20132017. Southeast Asia is the region that mainly drives overall profit growth. In 2013, the region accounted for 63.4 percent of the region's 36.4 percent of the region's income
Both domestic and export markets bring high value added. However, the southeast Asian market is still in its infancy, and the development of Australia and New Zealand is better. And it needs to import medical equipment from Europe, America and China. But as the domestic market for medical devices grows, foreign investment and exports will boost the consumption of raw materials in southeast Asia.
Polyvinyl chloride is still an important part of the asia-pacific market. It accounted for 32.5 percent of total revenue in 2013 because of a large number of disposable medical supplies in the region, particularly in southeast Asia. Due to the low price of PVC, good thermal stability and easy processing, the first choice of raw materials is used for the production of medical gloves and infusion equipment.
Because of his high transparency and high temperature resistance, polypropylene is the second choice. And very few allergies. In 2013, polypropylene accounted for 27.5% of total revenue and was widely used in the production of input devices such as syringes. The application of polyethylene is relatively small compared with polypropylene. More used in pharmaceutical packaging, accounting for 8.1% of the total income of other polymers for special purposes, such as radiation resistance.
Polyvinyl chloride (PVC) is widely used in the production of disposable medical supplies such as infusion bags and infusion tubes. Demand is still growing but at slower rates than polyolefins. Polypropylene is mainly used in the production of disposable syringes and will expand market share in other disposable medical plastics. As a substitute for polyvinyl chloride, polyethylene has a growing demand. In terms of sales channels, direct selling is the most important way of sales, accounting for 5% and 25% of pharmaceutical companies and dealers.
